News

Allergan has posted a net income of $169m for the first quarter of 2010, compared to $45m for the prior year period. Operating income was $250.3m, compared to

The quality agreement template was created to provide guidance for drafting agreements relating to the manufacture and release of drug substances regulated by the FDA. The template is

The license agreement is expected to enable Aragen Bioscience to offer its clients custom recombinant human cell lines expressing biotherapeutic proteins and antibodies as well as the transient

Progen Pharmaceuticals said that it had recently terminated its previous agreement with Global Transbiotech and was looking for a partner that could complete product development and commercialisation of

The investigational new drug application (IND) was reviewed through SFDA’s Green Channel expedited application process. The first patients were dosed on April 28, 2010. Sulfatinib (HMPL-012) is a

Avanir Pharmaceuticals expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval

Automaglia 90 Analyzer is a fully-automated analyzer for immunoassay analysis in various types of diseases and disorders. Major clinical diagnostic applications include thyroid disorders, fertility and infertility disorders,

The ANDA, which was developed and registered by Granules, is in collaboration with Heritage Pharmaceuticals, a generic pharmaceutical company. Under a previous agreement, Heritage retains exclusive sales and

Mnemonics said that the tool helps in inspecting multiple-page documents including batch inspection of labels, catalogs, instruction manuals, long manuscripts, magazines. Mnemonics claimed that AVIA Infinity makes proofreading